论文部分内容阅读
Purpose: To evaluate the efficacy and safety of intravitreal triamcinolone in patients with macular oedema of varying aetiology. Methods: Two milligrams of in travitreal triamcinolone acetonide was injected into 34 eyes with persistent mac ular oedema (17 eyes with macula oedema secondary to posterior uveitis, 13 eyes with diabetic retinopathy, and four with pseudophakic macular oedema). Best corr ected visual acuity was determined and transfoveal optical coherence tomography performed after 1 week, 1 month, 3 months and 6 months. Results: Treatment impro ved visual acuity and subjective visual quality, and reduced foveal thickness in eyes with posterior uveitis and eyes with macular oedema secondary to diabetic retinopathy. Eyes treated for pseudophakic cystoid macular oedema demonstrated n o improvement. A total of 32%of patients experienced a significant post-inject ion increase in intraocular pressure. Endophthalmitis, rhegmatogenous retinal de tachment and cataract were absent. Conclusion: Intravitreal triamcinolone appear s to induce marked a improvement in macular oedema secondary to non-infectious uveitis and diabetic retinopathy.
Purpose: To evaluate the efficacy and safety of intravitreal triamcinolone in patients with macular oedema of varying aetiology. Methods: Two milligrams of in travitreal triamcinolone acetonide was injected into 34 eyes with persistent macula edema (17 eyes with macula oedema secondary to posterior uveitis, 13 eyes with diabetic retinopathy, and four with pseudophakic macular oedema). Best corr ected visual acuity was determined and transfoveal optical coherence tomography performed after 1 week, 1 month, 3 months and 6 months. Results: Treatment impro ved visual acuity and subjective visual quality, and reduced foveal thickness in eyes with posterior uveitis and eyes with macular odedema secondary to diabetic retinopathy. A treated of pseudophakic cystoid macular odema with no improvement. A total of 32% of patients with a significant post-inject ion increase in intraocular pressure . Endophthalmitis, rhegmatogenous retinal de tachment and cataract were absent. Co nclusion: Intravitreal triamcinolone appear s to induce marked a improvement in macular oedema secondary to non-infectious uveitis and diabetic retinopathy.